Moderna Lifts Outlook, Swings to 3Q Profit

Morningstar · 2026-11-06 12:37 UTC

Moderna raised its full-year outlook as it swung to a profit and logged higher revenue in the recent quarter, boosted in part by stabilizing demand for its Covid-19 vaccine.

By Connor Hart

Moderna raised its full-year outlook as it swung to a profit and logged higher revenue in the recent quarter, boosted in part by stabilizing demand for its Covid-19 vaccine.

Shares were up 9.6% to $264.79 in premarket trading.

Read the full story at Morningstar · All coverage of this story